• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Multiple assessments of non-inferiority trials with ordinal endpoints.

作者信息

Xu Wenfu, Hou Yuli, Lu Tong-Yu

机构信息

College of Economics and Management, China Jiliang University, Hangzhou, China.

Department of Intelligent Medical, Baidu Company, Beijing, China.

出版信息

Stat Med. 2023 Apr 15;42(8):1113-1126. doi: 10.1002/sim.9660. Epub 2023 Jan 17.

DOI:10.1002/sim.9660
PMID:36650701
Abstract

Non-inferiority (NI) trials are implemented when there is a practical demand to search for alternatives to standard therapies, such as to reduce side effects. An experimental treatment is considered non-inferior to the standard treatment when it exhibits clinically non-significant loss of efficacy. Ordinal categorical responses are frequently observed in clinical trials. It has been reported that responses measured using an ordinal scale produce more informative analysis than when responses collapse into binary outcomes. We study the NI trials using ordinal endpoints. We propose a latent variable model for ordinal categorical responses. Based on the proposed latent variable model, the mean efficacy of the different treatments is denoted by the corresponding mean parameter of the underlying continuous distributions. A two-step procedure is proposed for model identification and parameter estimation. A non-inferiority analysis can then be conducted based on the latent variable model and the corresponding estimation procedure. We also develop a method and an algorithm to produce an optimal sample size configuration based on the proposed testing procedure. Two clinical examples are provided for demonstrative purposes.

摘要

相似文献

1
Multiple assessments of non-inferiority trials with ordinal endpoints.
Stat Med. 2023 Apr 15;42(8):1113-1126. doi: 10.1002/sim.9660. Epub 2023 Jan 17.
2
Multiple comparisons with two controls for ordered categorical responses.对有序分类反应与两个对照组进行多重比较。
J Biopharm Stat. 2017;27(1):111-123. doi: 10.1080/10543406.2016.1148707. Epub 2016 Feb 16.
3
A unified framework for the comparison of treatments with ordinal responses.用于比较具有有序反应的治疗方法的统一框架。
Psychometrika. 2014 Oct;79(4):605-20. doi: 10.1007/s11336-013-9367-8. Epub 2013 Nov 28.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Assessing toxicities in a clinical trial: Bayesian inference for ordinal data nested within categories.评估临床试验中的毒性:对嵌套于类别中的有序数据进行贝叶斯推断。
Biometrics. 2010 Sep;66(3):966-74. doi: 10.1111/j.1541-0420.2009.01359.x.
6
Comparison of two treatments with skewed ordinal responses.两种具有偏态有序反应的治疗方法的比较。
Stat Med. 2016 Jan 30;35(2):189-201. doi: 10.1002/sim.6626. Epub 2015 Aug 19.
7
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.处理非劣效试验中不确定的对照组事件风险:非劣效前沿和稳定功效转换。
Trials. 2020 Feb 6;21(1):145. doi: 10.1186/s13063-020-4070-4.
8
Multiple-arm superiority and non-inferiority designs with various endpoints.具有多种终点的多臂优效性和非劣效性设计。
Pharm Stat. 2007 Jan-Mar;6(1):43-52. doi: 10.1002/pst.242.
9
Confirmatory factor analysis with ordinal data: Comparing robust maximum likelihood and diagonally weighted least squares.有序数据的验证性因子分析:稳健极大似然法与对角加权最小二乘法的比较
Behav Res Methods. 2016 Sep;48(3):936-49. doi: 10.3758/s13428-015-0619-7.
10
Design of pharmacokinetic studies for latent covariates.潜伏协变量的药代动力学研究设计。
J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):87-97. doi: 10.1007/s10928-011-9231-3. Epub 2011 Dec 10.